Compare CVKD & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVKD | GENK |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 16.3M |
| IPO Year | 2023 | 2023 |
| Metric | CVKD | GENK |
|---|---|---|
| Price | $8.20 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $32.00 | $7.00 |
| AVG Volume (30 Days) | 43.2K | ★ 52.5K |
| Earning Date | 11-10-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $217,449,000.00 |
| Revenue This Year | N/A | $11.49 |
| Revenue Next Year | N/A | $13.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.36 |
| 52 Week Low | $8.12 | $2.20 |
| 52 Week High | $22.90 | $8.45 |
| Indicator | CVKD | GENK |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 36.68 |
| Support Level | $9.55 | $2.21 |
| Resistance Level | $12.50 | $2.41 |
| Average True Range (ATR) | 1.03 | 0.14 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 17.64 | 12.82 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.